LifeMap is a technology firm, and an emerging provider of digital mobile health products, including ResearchKit and HealthKit apps, in collaboration with the Icahn School of Medicine at Mount Sinai.
Peabody brings over 30 years of early stage company experience to LifeMap Solutions.
Since 2007, Peabody has helped LifeMap Solutions' parent company, BioTime, Inc., acquire and develop a portfolio of companies in the fields of regenerative medicine, diagnostics, and internet based genetic research.
LifeMap Solutions is developing digital health products in partnership with the Icahn Institute for Genomics and Multiscale Biology, which is located within the Icahn School of Medicine at Mount Sinai.
LifeMap digital therapeutic solutions integrate health and wellness information with care team guidance into a secure mHealth platform that empowers patients to make better choices to achieve optimal health outcomes. LifeMap Solutions is a subsidiary of BioTime, Inc. LifeMap Solutions is headquartered in San Jose, California.
Perrigo to acquire United States rights for Entocort from AstraZeneca
US FDA approves Boehringer Ingelheim's Pradaxa
Phase II clinical trial for potential treatment of androgenetic alopecia completed by Samumed
Life Sciences Partners collaborates on immuno-oncology with Bristol-Myers Squibb
Arsanis initiates first cohort in Phase one clinical trial of ASN100
Impax introduces generic Avodart (Dutasteride) Capsules, 0.5 mg
Mylan unveils generic FazaClo orally disintegrating tablets for treating schizophrenia